News Markets & Companies
Chemours releases second quarter 2026 results
The global chemistry company has published its financial results for the second quarter of 2026, reporting net sales of approximately USD 1.6 billion and a significant year-on-year improvement in free cash flow.
Chemours has reported its financial results for the second quarter of 2026. Net sales totalled USD 1,591 million, approximately flat compared with USD 1,615 million in the prior-year quarter. The year-on-year decline of around 1 % reflected a 4 % decrease in volumes, partially offset by a 2 % pricing increase across all business segments and a 1 % currency tailwind. Adjusted EBITDA was USD 247 million, compared with USD 260 million in the prior-year period. The company recorded a net loss of USD 274 million, or USD 1.81 per diluted share, compared with a net loss of USD 380 million, or USD 2.53 per diluted share, in Q2 2025.
Free cash flows improved 128 % year-on-year to USD 114 million, supported by stronger operating cash flows and net working capital improvements. The company also paid down EUR 230 million of its B-3 Euro-denominated term loan, reducing net leverage to 4.4x, with a year-end target of approximately 3.8x.
TiO2 pricing and segment performance
Within the Titanium Technologies (TT) segment, net sales rose 1 % year-on-year to USD 661 million, with TiO2 pigment sales reaching USD 639 million. A 2 % global pricing increase and a 1 % currency tailwind more than offset a 2 % volume decline. Sequentially, TT net sales grew 18 %, driven by a 15 % volume increase and a 3 % price rise. An additional global TiO2 price increase effective 1 June 2026 contributed to an approximately 5 % year-to-date price increase in net sales. Adjusted EBITDA for the segment edged up to USD 48 million, with the margin remaining flat at 7 %.
For the full year 2026, Chemours continues to anticipate net sales growth of between 1 % and 5 % over 2025, with adjusted EBITDA in the range of USD 775 million to USD 825 million.
